169 related articles for article (PubMed ID: 33294952)
21. A new prognostic model for hepatocellular carcinoma based on total tumor volume: the Taipei Integrated Scoring System.
Hsu CY; Huang YH; Hsia CY; Su CW; Lin HC; Loong CC; Chiou YY; Chiang JH; Lee PC; Huo TI; Lee SD
J Hepatol; 2010 Jul; 53(1):108-17. PubMed ID: 20451283
[TBL] [Abstract][Full Text] [Related]
22. [Evaluations of seven different clinical staging systems for Chinese patients with hepatocellular carcinoma undergoing curative resection].
Zhao J; Yan T; Huang Z; Bi X; Zhao H; Zhou J; Li Z; Li Y; Li C; Cai J
Zhonghua Yi Xue Za Zhi; 2014 Apr; 94(12):903-7. PubMed ID: 24854909
[TBL] [Abstract][Full Text] [Related]
23. Prognostic factors of disease-free and overall survival in patients with hepatocellular carcinoma undergoing partial hepatectomy in curative intent.
Lurje G; Bednarsch J; Czigany Z; Amygdalos I; Meister F; Schöning W; Ulmer TF; Foerster M; Dejong C; Neumann UP
Langenbecks Arch Surg; 2018 Nov; 403(7):851-861. PubMed ID: 30267147
[TBL] [Abstract][Full Text] [Related]
24. Importance of tumor size as a prognostic factor after partial liver resection for solitary hepatocellular carcinoma: Implications on the current AJCC staging system.
Goh BK; Teo JY; Chan CY; Lee SY; Jeyaraj P; Cheow PC; Chow PK; Ooi LL; Chung AY
J Surg Oncol; 2016 Jan; 113(1):89-93. PubMed ID: 26611492
[TBL] [Abstract][Full Text] [Related]
25. The prognosis and survival analysis according to seven staging systems of hepatocellular carcinoma following curative resection.
Choi SB; Lee JG; Kim KS; Yoon DS; Choi JS; Lee WJ; Kim BR
Hepatogastroenterology; 2008; 55(88):2140-5. PubMed ID: 19260493
[TBL] [Abstract][Full Text] [Related]
26. An Eastern Hepatobiliary Surgery Hospital Microvascular Invasion Scoring System in Predicting Prognosis of Patients with Hepatocellular Carcinoma and Microvascular Invasion After R0 Liver Resection: A Large-Scale, Multicenter Study.
Zhang XP; Wang K; Wei XB; Li LQ; Sun HC; Wen TF; Chai ZT; Chen ZH; Shi J; Guo WX; Xie D; Cong WM; Wu MC; Lau WY; Cheng SQ
Oncologist; 2019 Dec; 24(12):e1476-e1488. PubMed ID: 31138726
[TBL] [Abstract][Full Text] [Related]
27. Prognostic Nomograms Stratify Survival of Patients with Hepatocellular Carcinoma Without Portal Vein Tumor Thrombosis After Curative Resection.
Fu YP; Yi Y; Huang JL; Jing CY; Sun J; Ni XC; Lu ZF; Cao Y; Zhou J; Fan J; Qiu SJ
Oncologist; 2017 May; 22(5):561-569. PubMed ID: 28438885
[TBL] [Abstract][Full Text] [Related]
28. A new staging system for resectable hepatocellular carcinoma: comparison with six existing staging systems in a large Chinese cohort.
Yang T; Zhang J; Lu JH; Yang LQ; Yang GS; Wu MC; Yu WF
J Cancer Res Clin Oncol; 2011 May; 137(5):739-50. PubMed ID: 20607551
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of survival of patients with hepatocellular carcinoma: A comparative analysis of prognostic systems.
Tannus RK; Almeida-Carvalho SR; Loureiro-Matos CA; Miziara-Gonzalez A; Salzedas-Netto AA; Szejnfeld D; D'Ippolito G; Pereira-Lanzoni V; Souza-Silva I
PLoS One; 2018; 13(4):e0194922. PubMed ID: 29617435
[TBL] [Abstract][Full Text] [Related]
30. Comparative study of survival of patients with hepatocellular carcinoma predicted by different staging systems using multivariate analysis.
Nanashima A; Omagari K; Tobinaga S; Shibata K; Sumida Y; Mine M; Morino S; Shibasaki S; Ide N; Shindou H; Nagayasu T
Eur J Surg Oncol; 2005 Oct; 31(8):882-90. PubMed ID: 15993031
[TBL] [Abstract][Full Text] [Related]
31. Comparison of Liver Transplantation and Liver Resection for Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus Type I and Type II.
Lv JY; Zhang NN; Du YW; Wu Y; Song TQ; Zhang YM; Qu Y; Liu YX; Gu J; Wang ZY; Qiu YB; Yang B; Tian DZ; Guo QJ; Zhang L; Sun JS; Xie Y; Wang ZL; Sun X; Jiang WT; Lu W
Yonsei Med J; 2021 Jan; 62(1):29-40. PubMed ID: 33381932
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of eight different clinical staging systems associated with overall survival of chinese patients with hepatocellular carcinoma.
Zhao JJ; Yan T; Zhao H; Zhou JG; Huang Z; Zhang YF; Li Y; Li ZY; Bi XY; Cai JQ
Chin Med J (Engl); 2015 Feb; 128(3):316-21. PubMed ID: 25635426
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection.
Ji F; Fu S; Guo Z; Pang H; Chen D; Wang X; Ju W; Wang D; He X; Hua Y; Peng B
Oncotarget; 2016 Nov; 7(44):72276-72289. PubMed ID: 27472390
[TBL] [Abstract][Full Text] [Related]
34. Real-world role of performance status in surgical resection for hepatocellular carcinoma: A multicenter study.
Wu H; Xing H; Liang L; Huang B; Li C; Lau WY; Zhou YH; Gu WM; Wang H; Chen TH; Zhang YM; Zeng YY; Pawlik TM; Wang MD; Wu MC; Shen F; Yang T
Eur J Surg Oncol; 2019 Dec; 45(12):2360-2368. PubMed ID: 31543386
[TBL] [Abstract][Full Text] [Related]
35. Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter study.
Marasco G; Colecchia A; Bacchi Reggiani ML; Celsa C; Farinati F; Giannini EG; Benevento F; Rapaccini GL; Caturelli E; Di Marco M; Biasini E; Marra F; Morisco F; Foschi FG; Zoli M; Gasbarrini A; Baroni GS; Masotto A; Sacco R; Raimondo G; Azzaroli F; Mega A; Vidili G; Brunetto MR; Nardone G; Dajti E; Ravaioli F; Avanzato F; Festi D; Trevisani F;
Dig Liver Dis; 2021 Aug; 53(8):1011-1019. PubMed ID: 33353858
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of the prognostic powers of various tumor status grading scales in patients with hepatocellular carcinoma.
Seo YS; Kim YJ; Um SH; Yoo H; Lee JW; Kim YS; Jeen YT; Chun HJ; Kim CD; Ryu HS
J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 1):1267-75. PubMed ID: 18637054
[TBL] [Abstract][Full Text] [Related]
37. Validity of the Barcelona Clinic Liver Cancer and Hong Kong Liver Cancer staging systems for hepatocellular carcinoma in Singapore.
Selby LK; Tay RX; Woon WW; Low JK; Bei W; Shelat VG; Pang TC; Junnarkar SP
J Hepatobiliary Pancreat Sci; 2017 Mar; 24(3):143-152. PubMed ID: 28012284
[TBL] [Abstract][Full Text] [Related]
38. Incorporating albumin-bilirubin grade into the cancer of the liver Italian program system for hepatocellular carcinoma.
Chan AW; Chong CC; Mo FK; Wong J; Yeo W; Johnson PJ; Yu S; Lai PB; Chan AT; To KF; Chan SL
J Gastroenterol Hepatol; 2017 Jan; 32(1):221-228. PubMed ID: 27257086
[TBL] [Abstract][Full Text] [Related]
39. Prospective validation of the Barcelona Clinic Liver Cancer staging system.
Cillo U; Vitale A; Grigoletto F; Farinati F; Brolese A; Zanus G; Neri D; Boccagni P; Srsen N; D'Amico F; Ciarleglio FA; Bridda A; D'Amico DF
J Hepatol; 2006 Apr; 44(4):723-31. PubMed ID: 16488051
[TBL] [Abstract][Full Text] [Related]
40. [Clinical efficacy and prognostic factors analysis following curative hepatectomy for hepatocellular carcinoma patients with different China Liver Cancer Staging].
Li CX; Zhang H; Wu XF; Han S; Jiao CY; Wang D; Wang K; Li XC
Zhonghua Wai Ke Za Zhi; 2021 Feb; 59(2):134-143. PubMed ID: 33378806
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
